Humoral and cellular immune responses in atherosclerosis: spotlight on B- and T-cells (Q37983656)

26 August 2017

title

Humoral and cellular immune responses in atherosclerosis: spotlight on B- and T-cells (English)

1 reference

26 August 2017

1 reference

4

Alain Tedgui

1 reference

26 August 2017

3

Ziad Mallat

1 reference

26 August 2017

author name string

Padmapriya Ponnuswamy

series ordinal

1

1 reference

26 August 2017

Emily A Van Vré

series ordinal

2

1 reference

26 August 2017

publication date

8 February 2012

1 reference

26 August 2017

published in

Vascular Pharmacology

1 reference

26 August 2017

volume

56

1 reference

26 August 2017

issue

5-6

1 reference

26 August 2017

page(s)

193-203

1 reference

Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Natural regulatory T cells control the development of atherosclerosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

B cell depletion reduces the development of atherosclerosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

B-Lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Immunobiology of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

The double life of a B-1 cell: self-reactivity selects for protective effector functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Production of interleukin-13 by human dendritic cells after stimulation with protein allergens is a key factor for induction of T helper 2 cytokines and is associated with activation of signal transducer and activator of transcription-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

CD1 recognition by mouse NK1 T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

2. Cytokines and chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

IL-17A Is Proatherogenic in High-Fat Diet-Induced and Chlamydia pneumoniae Infection-Accelerated Atherosclerosis in Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Inhibition of IL-17A in atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Flt3 signaling-dependent dendritic cells protect against atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Interleukin-17A Deficiency Accelerates Unstable Atherosclerotic Plaque Formation in Apolipoprotein E-Deficient Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

B-lymphocyte effector functions in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

B-Cell Aortic Homing and Atheroprotection Depend on Id3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Deleting TCR alpha beta or CD4 T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Anti-endothelial cell antibodies are increased in patients with previous myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

GATA-3 significantly downregulates IFN-gamma production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Differential effects of regulatory T cells on the initiation and regression of atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

A Critical Function of Th17 Proinflammatory Cells in the Development of Atherosclerotic Plaque in Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Raising the NKT cell family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

IFN-gamma potentiates atherosclerosis in ApoE knock-out mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

The opposite-direction modulation of CD4 CD25 Tregs and T helper 1 cells in acute coronary syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

The immune system in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Downregulation of T helper cell type 3 in patients with acute coronary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Review of human DC subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Dendritic-cell control of pathogen-driven T-cell polarization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Antibodies against the human heat shock protein hsp70 in patients with severe coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Signal transducer and activator of transcription-1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

The role of CD4 CD25 regulatory T cells in macrophage-derived foam-cell formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Th17 and regulatory T cells in mediating and restraining inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Requirement for CD154 in the progression of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

CD40 and its ligand in atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Foxp3 -Inducible Regulatory T Cells Suppress Endothelial Activation and Leukocyte Recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Quantitative and Qualitative Differences in Proatherogenic NKT Cells in Apolipoprotein E–Deficient Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Interleukin-18/Interleukin-18 Binding Protein Signaling Modulates Atherosclerotic Lesion Development and Stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Regulatory T-cell immunity in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Macrophage diversity and polarization in atherosclerosis: a question of balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE−/− mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

IL-33 reduces the development of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Autoantibodies against the endothelial receptor of protein C are associated with acute myocardial infarction in young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Macrophages in the Pathogenesis of Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Altered status of CD4( )CD25( ) regulatory T cells in patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Role of naturally occurring CD4 CD25 regulatory T cells in experimental atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

An immunohistochemical analysis of human aortic fatty streaks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Natural killer T cells accelerate atherogenesis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Attenuated Atherosclerotic Lesions in apoE-Fcγ–Chain-Deficient Hyperlipidemic Mouse Model Is Associated with Inhibition of Th17 Cells and Promotion of Regulatory T Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

The biological functions of T helper 17 cell effector cytokines in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Variation in susceptibility to atherosclerosis among inbred strains of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F(2alpha)-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Disruption of TGF-β signaling in T cells accelerates atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

IL-17A inhibits the expansion of IL-17A-producing T cells in mice through "short-loop" inhibition via IL-17 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

A novel transcription factor, T-bet, directs Th1 lineage commitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Regulatory T-cell immunity and its relevance to atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Interleukin-17: friend or foe in atherosclerosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Type I natural killer T cells: naturally born for fighting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Cytokines in atherosclerosis: pathogenic and regulatory pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

CD1d-dependent activation of NKT cells aggravates atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Vaccination against Foxp3( ) regulatory T cells aggravates atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Invariant natural killer T cells: bridging innate and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Effect of natural killer T cell activation on the initiation of atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Dendritic Cells in Human Atherosclerosis: From Circulation to Atherosclerotic Plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Regulatory B cells: Evidence, developmental origin and population diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe–/– mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Atherosclerosis: current pathogenesis and therapeutic options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Role of heat shock proteins in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis : clinical significance determined in a follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

A regulatory B cell subset with a unique CD1dhiCD5 phenotype controls T cell-dependent inflammatory responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Plasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Transfer of CD4( ) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

Induction of T-cell activation by oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2012.01.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VPH.2012.01.009

1 reference

26 August 2017

1 reference